PapersFlow Research Brief
Leptospirosis research and findings
Research Guide
What is Leptospirosis research and findings?
Leptospirosis research and findings encompass studies on the zoonotic bacterial disease caused by Leptospira species, covering molecular genetics, pathogenicity, epidemiology, diagnosis, virulence, vaccine development, and host immune responses.
Leptospirosis research includes 36,882 works focused on the zoonotic disease caused by Leptospira bacteria. Key areas address molecular genetics, pathogenicity, epidemiology, diagnosis, virulence, vaccine development, and host immune response. The field highlights leptospirosis as a disease of global public health importance with higher incidence in tropical regions.
Topic Hierarchy
Research Sub-Topics
Leptospira Molecular Genetics
This sub-topic explores genome sequencing, transposon mutagenesis, and genetic regulation in Leptospira species. Researchers identify virulence genes and evolutionary adaptations.
Leptospirosis Epidemiology
This sub-topic studies incidence patterns, risk factors, and spatiotemporal dynamics of leptospirosis outbreaks globally. Researchers use surveillance data and modeling for burden estimation.
Leptospirosis Pathogenicity Mechanisms
This sub-topic investigates adhesion, invasion, and toxin production by Leptospira during infection. Researchers employ animal models and cell culture assays.
Leptospirosis Diagnosis Methods
This sub-topic evaluates serological tests, PCR assays, and rapid diagnostics for early leptospirosis detection. Researchers assess sensitivity, specificity, and field applicability.
Leptospirosis Vaccine Development
This sub-topic focuses on subunit vaccines, live-attenuated strains, and immunogenicity studies against diverse Leptospira serovars. Researchers conduct preclinical trials.
Why It Matters
Leptospirosis research documents the disease as a leading zoonotic cause of morbidity and mortality worldwide, with highest burdens in resource-poor countries. "Global Morbidity and Mortality of Leptospirosis: A Systematic Review" (Costa et al., 2015) estimated that leptospirosis accounts for numbers of deaths approaching or exceeding those for other causes of haemorrhagic fever. "Leptospirosis: a zoonotic disease of global importance" (Bharti et al., 2003) emphasized its impact on impoverished populations through outbreaks linked to flooding and poor sanitation. "Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing" (Wilson et al., 2014) demonstrated next-generation sequencing enabling diagnosis in a 14-year-old boy with severe combined immunodeficiency who progressed to hydrocephalus and status epilepticus after initial failures of conventional tests.
Reading Guide
Where to Start
"Leptospirosis" by Paul N. Levett (2001) provides a foundational review of the disease's epidemiology, clinical features, and global emergence, making it ideal for initial reading.
Key Papers Explained
"Leptospirosis: a zoonotic disease of global importance" (Bharti et al., 2003) establishes the disease's worldwide importance, which "Leptospirosis" (Levett, 2001) expands with detailed clinical microbiology and epidemiology. "Leptospira and leptospirosis" (Adler and de la Peña Moctezuma, 2009) builds by focusing on bacterial biology and pathogenicity mechanisms. "Global Morbidity and Mortality of Leptospirosis: A Systematic Review" (Costa et al., 2015) quantifies the burden using systematic data synthesis from prior epidemiological works. "Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen" (Ko et al., 2009) advances genetic insights to address gaps in pathogenesis noted earlier.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes molecular genetics for pathogenesis and vaccine targets, as in "Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen" (Ko et al., 2009). Diagnostic innovations like next-generation sequencing from "Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing" (Wilson et al., 2014) represent frontiers. No recent preprints or news indicate ongoing focus on global morbidity estimates and host responses.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Schalm's Veterinary Hematology | 2022 | — | 2.9K | ✕ |
| 2 | Leptospirosis: a zoonotic disease of global importance | 2003 | The Lancet Infectious ... | 2.4K | ✕ |
| 3 | Leptospirosis | 2001 | Clinical Microbiology ... | 2.3K | ✓ |
| 4 | Leptospira and leptospirosis | 2009 | Veterinary Microbiology | 2.3K | ✕ |
| 5 | Global Morbidity and Mortality of Leptospirosis: A Systematic ... | 2015 | PLoS neglected tropica... | 1.9K | ✓ |
| 6 | Global Epidemiology of Campylobacter Infection | 2015 | Clinical Microbiology ... | 1.4K | ✓ |
| 7 | Actionable Diagnosis of Neuroleptospirosis by Next-Generation ... | 2014 | New England Journal of... | 999 | ✓ |
| 8 | Leptospirosis in Humans | 2014 | Current topics in micr... | 932 | ✕ |
| 9 | Leptospira: the dawn of the molecular genetics era for an emer... | 2009 | Nature Reviews Microbi... | 860 | ✓ |
| 10 | Spirochetes Isolated from the Blood of Two Patients with Lyme ... | 1983 | New England Journal of... | 815 | ✕ |
Frequently Asked Questions
What causes leptospirosis?
Leptospirosis is caused by the spirochaetal bacterium Leptospira. "Leptospira and leptospirosis" (Adler and de la Peña Moctezuma, 2009) details Leptospira species as the etiologic agents transmitted zoonotically. The disease manifests with greater incidence in tropical regions.
How is leptospirosis diagnosed?
Diagnosis involves serological tests, culture, and molecular methods. "Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing" (Wilson et al., 2014) showed next-generation sequencing identifying Leptospira in cerebrospinal fluid after brain biopsy failed. "Leptospirosis" (Levett, 2001) notes epidemiology modified by animal husbandry, climate, and human behavior aids diagnostic context.
What is the global burden of leptospirosis?
Leptospirosis ranks among leading zoonotic causes of morbidity with high mortality in resource-poor areas. "Global Morbidity and Mortality of Leptospirosis: A Systematic Review" (Costa et al., 2015) found highest morbidity and mortality in regions with burdened populations. It approaches deaths from other haemorrhagic fevers.
What advances exist in leptospirosis molecular genetics?
Molecular genetics research targets pathogenesis and virulence factors. "Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen" (Ko et al., 2009) marks progress 100 years post-discovery of Leptospira. This supports vaccine development and understanding host immune responses.
What are key features of leptospirosis in humans?
Human leptospirosis presents as an emerging infection with resurgent outbreaks. "Leptospirosis in Humans" (Haake and Levett, 2014) covers clinical manifestations and transmission. "Leptospirosis: a zoonotic disease of global importance" (Bharti et al., 2003) underscores its worldwide significance.
Open Research Questions
- ? How do Leptospira virulence factors interact with host immune responses to cause severe disease outcomes?
- ? What epidemiological factors drive resurgent leptospirosis outbreaks in tropical regions?
- ? Can molecular genetics approaches accelerate effective vaccine development against diverse Leptospira serovars?
- ? How does climate change modify leptospirosis transmission patterns globally?
- ? What diagnostic improvements are needed for early detection in resource-poor settings?
Recent Trends
The field comprises 36,882 works with no specified 5-year growth rate.
Highly cited reviews like "Leptospirosis: a zoonotic disease of global importance" (Bharti et al., 2003, 2418 citations) and "Leptospirosis" (Levett, 2001, 2298 citations) anchor foundational knowledge.
Absence of recent preprints or news coverage suggests stable emphasis on epidemiology, diagnostics, and molecular genetics without noted shifts.
Research Leptospirosis research and findings with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Leptospirosis research and findings with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers